Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Aggression × Dexamethasone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 379 Precursor Cell Lymphoblastic Leukemia-Lymphoma 109 Neoplasms, Plasma Cell 68 Recurrence 59 Lymphoma 52 Leukemia 49 Neoplasms 44 Vomiting 35 Immunoglobulin Light-chain Amyloidosis 33 Burkitt Lymphoma 33 Lymphoma, Mantle-Cell 30 Lymphoma, Large B-Cell, Diffuse 26 Nausea 25 Lymphoma, Non-Hodgkin 24 Breast Neoplasms 22 Waldenstrom Macroglobulinemia 21 Lymphoma, Follicular 21 Leukemia, Lymphocytic, Chronic, B-Cell 19 Hodgkin Disease 19 Prostatic Neoplasms 15 Neoplasm Metastasis 15 Lymphoma, Extranodal NK-T-Cell 15 Leukemia, Myeloid, Acute 15 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 14 Amyloidosis 13 Smoldering Multiple Myeloma 12 Lymphoma, B-Cell, Marginal Zone 12 Lung Neoplasms 11 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 9 Lymphoma, Large-Cell, Immunoblastic 9

Interventions

selinexor 1 pegfilgrastim 1 Topotecan 1 Rituximab 1 Prednisone 1 Positron Emission Tomography Computed Tomography 1 Paclitaxel 1 Methylprednisolone 1 Immunologic Techniques 1 Ifosfamide 1 Flow Cytometry 1 Etoposide 1 Dexamethasone 1 Clofarabine 1 Carboplatin 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02471911 2022-04-12

KPT-330+RICE

Weill Medical College of Cornell University

Phase 1 Completed

Aggression, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡